Drug Side Effects
Search
OESOPHAGEAL WALL HYPERTROPHY
OESOPHAGEAL WALL HYPERTROPHY
was reported 34 times
OESOPHAGEAL WALL HYPERTROPHY is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Phenylalanine Metabolizing Enzyme [EPC]
1
0.0001
1
Human Immunoglobulin G [EPC]
1
0.0000
2
Parathyroid Hormone-Related Peptide Analog [EPC]
1
0.0000
3
Nucleoside Metabolic Inhibitor [EPC]
7
0.0000
4
General Anesthetic [EPC]
1
0.0000
5
Programmed Death Receptor-1 Blocking Antibody [EPC]
2
0.0000
6
Platinum-based Drug [EPC]
4
0.0000
7
HER2/neu Receptor Antagonist [EPC]
1
0.0000
8
Catecholamine [EPC]
1
0.0000
9
Histamine-1 Receptor Antagonist [EPC]
1
0.0000
10
beta-Adrenergic Blocker [EPC]
3
0.0000
11
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
1
0.0000
12
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
1
0.0000
13
Calcium [EPC]
1
0.0000
14
Janus Kinase Inhibitor [EPC]
1
0.0000
15
Xanthine Oxidase Inhibitor [EPC]
1
0.0000
16
Expectorant [EPC]
1
0.0000
17
GLP-1 Receptor Agonist [EPC]
2
0.0000
18
Atypical Antipsychotic [EPC]
2
0.0000
19
Opioid Agonist [EPC]
1
0.0000
20
Proton Pump Inhibitor [EPC]
2
0.0000
21
Osmotic Laxative [EPC]
1
0.0000
22
Nonsteroidal Anti-inflammatory Drug [EPC]
3
0.0000
23
Loop Diuretic [EPC]
1
0.0000
24
Interleukin-4 Receptor alpha Antagonist [EPC]
1
0.0000
25
Kinase Inhibitor [EPC]
1
0.0000